Anatomy of a bowling ball: How Storm Products makes balls in Brigham City – Standard-Examiner

Like the wheel, it might seem like theres no re-inventing a ball, but the minds at Storm Products, Inc. have been doing it for decades.

Theres more to high-performance bowling balls than meets the eye. Theyre designed for all kinds of skill, style and conditions. Tavio Sawyer, Storms creative director, compares them to golf clubs.

Like golf clubs, (serious) bowlers have more than one ball they carry, he said.The lane is like a fairway or the green it changes.

RELATED: Brigham-based bowling ball maker looks for new market

To understand the nuances of ball technology and how theyre built to perform in different ways, it helps to peek inside.

Core

At the heart of the ball is its weight block, which varies in size and shape. Some look like lightbulbs, some look like fishing reels, some look like spinning tops. Others are completely symmetrical and round.

The weight blocks drive how the ball performs how and when it curves or hooks, how fast it revs and where it rotates on the balls axis.

Thats the idea of the shapes, said Chad McLean, Storms technical staff manager.Then all these nooks, crannies and different things make the ball do something different.

Bowlers select different cores to match their throwing style and for spare balls when they need to throw at different angles.

The weight block is the balls core. Some are wrapped in a white cover material, some blocks are wrapped directly in the cover stock.

Cover stock

The cover stock is the part of the ball you see. In the early days, balls were made of wood. By the early 1900s, they were made of rubber. Now theyre mostly made of resins and urethane, although free house balls provided at bowling centers are made of plastic.

Cover stock comes in a variety of colors and finishes. Storm infuses theirs with different scents, like birthday cake, strawberry lemonade and caramel pecan.

A bowler picks cover stock colors and smell to meet her taste, but finishes have a more specific purpose. They have a microscopic tread meant to handle different oil conditions on the bowling lane.

Sawyer compares the core to a cars engine and the cover stock to tires.

The engine makes it move, but the tires help cut through the oil, he said. If you have no polish, its going to absorb more oil if oil on the lane gets really heavy, instead of throwing this thing thats going to hydroplane, you want something that will cut through the oil ... so that when it gets to the part in which a ball needs to hook, the ball still has enough power to do that.

Oil conditions vary from lane to lane and the amount of traffic a lanes seen. Experienced bowlers know how to read the lanes and select the right ball for oil conditions.

Holes

Pro shops drill custom finger holes to fit a bowlers hand. Those finger holes are placed on different parts of the ball, depending on the bowlers style.

Where you put holes in relationship to core inside makes that ball unique, McLean said. You can have three of the same exact ball, but put the holes in different spots, and youre going to have three different balls.

Visit link:
Anatomy of a bowling ball: How Storm Products makes balls in Brigham City - Standard-Examiner

How behavioral science can improve retirement plan health … – BenefitsPro

The online activity of participants on a retirement plan website reinforces that people are prone to making quick, instinctive decisions about investments. (Photo: Getty)

Theres no denying that Americans today are shouldering greater responsibility for their retirement security than ever before.

With uncertainty around the future of Social Security, the increasing costs associated with living longer, and the fact that people are not saving enough, the average worker faces the growing risk that they will not have the income they need to meet their retirement goals.

Every plan should consider one or more of these strategies, if they havent already:

1. Automatic enrollment One of the best ways to help sponsors advance their employees retirement goals is to first make sure they are on the path to saving through auto-enrollment.

Industry research has found that this step can increase enrollment by approximately 10 percent. Advisors should encourage clients to adopt auto-enrollment policies, reducing the number of employees who get overlooked or sidetracked before even signing up for their plan.

Go here to read the rest:
How behavioral science can improve retirement plan health ... - BenefitsPro

Behavioral science can trick you into doing the right thing – AARP News

On the contrarywe often choose immediate rewards over higher future benefits. We take the path of least resistance, typically by going with the status quo or simply doing nothing.

Seduced to Act

Take saving for retirement. We all know it's important, yet studies show that many of us haven't done a good job of it. Enter behavioral economics. One of its most successful applications has been to get workers to participate in retirement savings plans. For decades, employers cajoled workerseven offering generous matching contributionsto sign up for the 401(k). But human inertia often won out, and many workers didn't join.

Then employerswith a green light from Uncle Samstarted to automatically enroll workers in the plan; some even gradually increased employees' contributions over time. Workers can opt out, of course.

But inertia, now working in favor of savings, stops them from doing so. Vanguard, an investment firm that administers 401(k) plans for employers, found that when companies auto-enroll workers, the participation rates among new hires more than double, to about 90 percent.

The good news is that a growing number of employers, companies and nonprofits are using behavioral insights in similar ways to influence choices to make people better off. Here are six examples.

Making investment decisions easier

Too many 401(k) investment choices can overwhelm, causing workers to put off making any decision.

And even when they do select investments, human inertia often causes them never to revisit their choices. Over time, their portfolios can end up being heavily weighted in riskier stocks, putting their nest egg in jeopardy.

The solution: target-date retirement funds. Workers need to select only a single fund with the date closest to their retirement, and a professional money manager does the restinvesting aggressively when workers are younger and gradually becoming more conservative as they near retirement. Target-date funds are usually the default option when employers automatically enroll workers in 401(k)s and now are found in 9 out of 10 workplace plans, according to Aon Hewitt, a benefit consulting firm.

See the rest here:
Behavioral science can trick you into doing the right thing - AARP News

We! A recipe for happiness – The San Diego Union-Tribune

Norway is the happiest country on Earth, according to the 2017 World Happiness Report. Not far behind Norway are Denmark, Iceland, Switzerland and Finland. The next five are the Netherlands, Canada, New Zealand, Australia and Sweden. The United States came in at No. 14 (out of 155).

This got me to thinking about what makes for happiness?

As far back as the 1960s, when Transactional Analysis (Im OK, Youre OK) and gestalt theories were in full bloom, I was fascinated by the various concepts of behavioral psychology. I attended workshops on T/A, had the rare pleasure of taking courses at Union College with the noted Professor Clare Graves, read widely the teachings of Maslow, et al., and eventually added a degree with a focus on behavioral science.

Among the various aspects of this field of study are concepts of individualistic veusus. social behavior. Dr. Graves has published extensive research on the maturing of the human brain, which featured cycling between individualistic and social behavior through eight stages. Noted cultural anthropologist Margaret Mead published a study of eight cultures, half of which she considered wholesome and the others remembered as unwholesome. She searched for commonalities among the four better societies and among the four worse ones. What she found was that the better ones exhibited greater social tendencies, working together for the common good, as opposed to individualistic behavior more of a dog-eat-dog culture.

To attempt to condense the findings of all of the research on human behavior would be well above my pay grade and futile within a 700-word limit. But I am moved to share a simple, maybe even naive, hypothesis, derived from the studies of individualistic and social behavior.

Lets start by considering two types of people. One has a dominant personality of individuality. The other is driven by social behavior. Ill call the first one Me and the other We. The Me person leans toward a zero-sum mentality. I have to fight for my share of the pie. What someone else has is not available to me. Whereas, the We person buys into the concept that a rising tide lifts all ships. The We person believes in synergy. That is: the product of a group, working together, exceeds the sum of the individual efforts and contributions.

Its not difficult to understand why and how people operate within these two personas. Individualistic behavior is one way of coping with fear. Such a person may not trust others to be concerned with his or her welfare. Individualist behavior can be driven by insecurity feeling in danger. Or sometimes, individualistic behavior is driven by greed, the need to take whatever is up for grabs.

On the other hand, social behavior can also deal with fear and insecurity. Faced with threats, We people tend to gather together, believing that pooling skills and resources will bring greater safety and rewards to all. I realize that there are reasonable arguments in support of both philosophies and that the subject is much more complex than this.

So what does this have to do with happiness? A fundamental characteristic of the Me person is to derive pleasure from doing things that make him happy. Conversely, the We person gains pleasure out of making others happy. Its sort of a two-for-one deal. By contributing to someone elses pleasure or satisfaction, We people make themselves happy.

It surely cant be that simple. Or can it?

Relate this to governance. With a Me focus, a nation can be prosperous, but such prosperity is only enjoyed by a small portion of the population. As a result, only a small group experiences happiness and those who, for a multitude of possible reasons, cannot reap the rewards are left to suffer. With a Me focus, a large part of the population may be overlooked by the system. Such people will fear being without a home, food, healthcare and other human essentials. This, in turn, will certainly take a toll on the nations happiness index. On the other hand, We people tend to spread the happiness around.

This brings me back to the Happiness Report. Most of the top nations in that list are ones where a We perspective dominates their societies. Can this be mere coincidence?

A Rancho Bernardo resident, Levine is a retired project management consultant and the author of three books on the subject. Reader comments, through letters to the editor, are encouraged.

Read the original post:
We! A recipe for happiness - The San Diego Union-Tribune

Shatori Walker-Kimbrough ‘nervous’ in preseason debut as Mystics … – Washington Post

With 11 days left until their regular season opener, the Washington Mystics were back in the gym Wednesday afternoon less than 24 hours after defeating the Indiana Fever, 87-67, in their preseason opener in Indianapolis.

Coach Mike Thibault spent the final portion of practice on the main court at Verizon Center working on end-of-game situations. In one drill, prized offseason acquisition Elena Delle Donne stepped into the passing lane for a steal to preserve a lead. Moments later rookie Shatori Walker-Kimbrough did the same.

Its a play the No. 6 pick in this years draft made time and again while at Maryland, where she completed her career this past season as the schools fourth all-time scorer.The guard-forward also developed into a responsible defender, leading the Terrapins in steals as a senior.

Walker-Kimbrough finished with 12 points in 20 minutes in Tuesdays exhibition, logging the most playing time among the starters at a venue where she shined in college. As a junior, Walker-Kimbrough was named most outstanding player in helping the Terrapins win the Big Ten tournament title at Bankers Life Fieldhouse.

[Elena Delle Donne sharp as Mystics beat Fever in preseason opener]

Im not going to lie. I was a little nervous, Walker-Kimbrough said of her professional debut. Its so crazy just being out there actually going against a different team. Its like so surreal to me, but it went great. I thought we played really good as a team.

Honing team chemistry has been a priority during training camp given the many newcomers to the club. Just two starters against the Fever were with Washington last season, and among the seven reserves who played, only forwards Tianna Hawkins and Ally Malott have experience in a Mystics uniform.

Thibault held out starting guard Tayler Hill because of a sore ankle, and backup point guard Ivory Latta did not play while sherests her surgically repaired knee. Also missing from the lineup were Emma Meesseman and Kristi Toliver, both starters who have yet to come back from playing overseas.

Meesseman and Toliver are expected back next week, but not in time for the final preseason game Monday night against the Minnesota Lynx at Verizon Center.

I thought it was good just to get out there against a different team, said forward Asia Taylor, who came off the bench to lead Washington with 13 points against the Fever. I liked our energy we came out with. I liked that coach put us out there with different lineups and different matchups, and I got to play a bunch of different positions, which was good for me to just kind of get out there and put everything together weve been doing in practice.

[After 10 seasons in the WNBA, Ivory Latta remains Mystics bundle of energy]

The next few days of practice are set to include, among other assignments, installing more offensive sets, Thibault indicated. The Mystics are somewhat limited in what they can do in that regard in part because of the absence of Toliver, the starting point guard.

Still, getting Delle Donne more comfortable within the offense remains an ongoing process, with the next step scripting plays designed especially for the 2015 WNBA MVP. Delle Donne joined the Mystics in a blockbuster offseason trade with the Chicago Sky in which Thibault, also the general manager, dealt the No. 2 overall pick this year, center Stefanie Dolson and guard Kahleah Copper in exchange for the then-restricted free agent.

Delle Donne had 12 points, three assists and two rebounds in 17 minutes against the Fever while frequently matched against forward Candice Dupree, a five-time all-star.

We arent running that many plays right now, and were certainly not running plays designed for individuals at the moment, Thibault said. She had a good flow [against Indiana]. The goal is to play her between 15 and 18 minutes and kind of get her out there particularly when they had Dupree and those guys on the court. I thought it was a good start.

The rest is here:
Shatori Walker-Kimbrough 'nervous' in preseason debut as Mystics ... - Washington Post

With More Light, Chemistry Speeds Up – R & D Magazine

Light initiates many chemical reactions. Experiments at theLaser Centre of the Institute of Physical Chemistry of the Polish Academy of Sciences and the University of Warsaw's Faculty of Physicshave for the first time demonstrated that increasing the intensity of illumination some reactions can be significantly faster. Here, acceleration was achieved using pairs of ultrashort laser pulses.

Light-induced reactions can be accelerated by increasing the intensity of illumination -- this has been demonstrated in experiments carried out at the Institute of Physical Chemistry of the Polish Academy of Sciences (IPC PAS) in Warsaw. In order to thoroughly investigate the nature of the processes involved, ultra-short consecutive pairs of laser pulses were used, and an increase in the rate of reaction between the molecules was observed by up to several dozen percent. The observations of the Warsaw scientists have been reported in the well-known scientific journalPhysical Chemistry Chemical Physics.

"Our experiments provide fundamental knowledge about the physical processes that are important for the course of important light-induced reactions. This knowledge can potentially be used in many applications, especially when dealing with high intensity light sources. These include, among others, various microscopic imaging techniques, ultra-fast spectroscopy as well as photovoltaics, particularly if light-focusing devices such as solar collectors are used," says Dr. Gonzalo Angulo (IPC PAS).

In light-induced reactions, a photon with the appropriate energy excites a molecule of dye. When there is a molecule of quencher near the excited molecule, an interaction takes place: there may be a transfer of energy, an electron or a proton, between the two reactants. Reactions of this type are common in nature. A good example is electron transfer in photosynthesis, which plays a key role in the formation of the Earth's ecosystem.

It turns out that a factor that can influence the acceleration of reactions is the intensity of the light that initiates them. In order to study the nature of the processes taking place, the Warsaw chemists used laser pulses lasting femtoseconds instead of the traditional continuous stream of light. The energy of the impulses was adjusted so that, under their influence, the dye molecules moved into the excited energy state. The pulses were grouped in pairs. The interval between pulses in a pair was several dozen picoseconds (trillionths of a second) and was matched to the type of reacting molecules and the environment of the solution.

"The theory and the experiments required care and attention, but the physical idea itself is quite simple here," notes Jadwiga Milkiewicz, a PhD student at IPC PAS, and explains: "In order for the reaction to occur, there must be a molecule of quencher near the light-excited dye molecule. So, if we have a pair of molecules that have already reacted with each other this means that they were close enough to each other. By increasing the number of photons in time, we thus increase the chance that if, after the reaction, both molecules have managed to return to their ground state, the absorption of a new photon by the dye has the potential to initiate another reaction before the molecules move away from each other in space."

The course of reactions in solutions depends on many factors such as temperature, pressure, viscosity or the presence of an electric or magnetic field. The research at the IPC PAS has proved that these factors also influence the acceleration of the chemical reaction that occurs with an increased intensity of illumination. Under some conditions, the acceleration of the reaction was unnoticeable, in optimal conditions the rate of the reaction increased by up to 25-30%.

"In our experiments so far, we have concentrated on light-induced electron transfer reactions, that is, those which change the electrical charge of the molecules. However, we do not see any reason why the mechanism we have observed could not function in other variations of these reactions. So, in the near future, we will try to confirm its efficacy in energy transfer reactions or in reactions involving also proton transfer," says Dr. Angulo.

See the original post:
With More Light, Chemistry Speeds Up - R & D Magazine

Joe Flacco, Breshad Perriman finally have chance to build chemistry … – Baltimore Beatdown

The Ravens front office did not draft a receiver. Inhale, exhale and relax. Not only is there still time in the offseason, but the receivers on the roster, notably Breshad Perriman, still have a lot to prove and have not had the time to prove it.

Barring injury (please God) this will be Perriman's first complete offseason. He now has chance to enter and undergo a full training camp, therefore practicing with the maximum ammount of reps.

The lack of chemistry with Joe Flacco was apparent this past season, especially on stop routes along the sidelines where Flacco's ball placement was often wayward and the ball was being thrown much after Perriman turned around.

If Perriman and Flacco can go through an entire training camp and an entire pre-season together, the resulting chemistry gained could help mitigate the loss of Steve Smith, and perhaps even help Breshad Perriman ascend as a number one wide receiver.

Perriman and Flacco have a lot of things to iron out. Perriman still fights the ball and his transition to a runner after catching the ball is still not as smooth as it could be. The timing on routes that demand to be sharp - like slants, comebacks and back shoulder fades was not present last year. They have the opportunity to make big strides in the coming offseason. It would not be a stretch to say that it is paramount for the two players in question to find their groove.

Read the original here:
Joe Flacco, Breshad Perriman finally have chance to build chemistry ... - Baltimore Beatdown

Plandai Biotechnology Expanding Footprint of Phytofare into U.S. with Continued Sales – Yahoo Finance

NEW YORK, NY--(Marketwired - May 04, 2017) - Planda Biotechnology (PLPL) announced last week that its highly bioavailable Phytofare Catechin Complex would be the active ingredient in Capital Brand's reformulated and soon-to-be released SuperFood Fat Burning Boost, which is used with the well-known brand NutriBullet. This week we learned that thanks to a deal with Coyne Healthcare -- Planda's signature brand Phytofare will make its way to the U.S. and Europe as the star ingredient in Coyne Healthcare's product Origine 8.

Coyne Healthcare placed an order for 1.2 million of Planda's Origine 8 capsules, which is a product that not only uses the highly bioavailable green tea extract, Phytofare Catechin Complex, but further enhances the bioavailability of the extract by using an advanced liposome technology developed and clinically validated to improve the delivery of nutritional substances.

Origine 8 is a product that entraps all 8 of the catechins of the tea plant, and according to Planda, it is the only catechin-based capsule on the market backed by human clinical studies that prove it has superior bioavailability.

Coyne Healthcare has already been selling Planda's unique product in South Africa, but it now expects to launch Origine 8 this month in both the U.S. and Europe. The good news for Planda is that Coyne Healthcare has forecasted sales of 10.6 million Origine 8 capsules in 2017, and Coyne expects sales to further increase to 24 million Origine 8 capsules in 2018.

Coyne makes its products (http://coynehealthcare.co.za/#products) available through pharmacies, health food stores and medical practitioners, so for both NutriBullet and Coyne Healthcare to bring Planda's signature brand to the U.S., investors will have a great opportunity to physically see their investment up close and personal.

Sales at Planda and the recognition that the company is gaining globally, is clearly a response to the efforts made by the new COO, Callum Cottrell-Duffield, well before now. He led the company's sales and marketing team in its effort to grow the brand and expand the company's footprint worldwide after Planda's signature product was available for mass production and ready to market on a much broader scale last year. His work to increase sales and marketing throughout Africa, the United States, Europe, Asia and South America by telling the Planda story, is starting to pay off now in 2017.

And, with brands like NutriBullet and Coyne Healthcare, who both use and market only the highest quality ingredients in their products, advertising the Phytofare name, it shouldn't take long for Planda to grow quite an impressive sales footprint worldwide.

About Stock Market Media Group

Stock Market Media Group is a Content Development IR firm offering a platform for corporate stories to unfold in the media with research reports, corporate videos, CEO interviews and feature news articles.

We may from time to time include our own opinions about our featured companies, their businesses, markets and opportunities. Any opinions we may offer are solely our own, and are made in reliance upon our rights under the First Amendment to the U.S. Constitution, and are provided solely for the general opinionated discussion of our readers and viewers. Our opinions should not be considered to be complete, precise, accurate, or current investment advice, or construed or interpreted as research. Any investment decisions you may make concerning any company are solely your responsibility based on your own due diligence. Our publications are provided only as an informational aid. We encourage you to invest carefully and read the investor information available at the web site of the U.S. Securities and Exchange Commission at: http://www.sec.gov. We also recommend as a general rule, that before investing in any securities you consult with a professional financial planner or advisor, and you should conduct a complete and independent investigation before investing in any security after prudent consideration of all pertinent risks.

We are not a registered broker, dealer, analyst, or adviser. We hold no investment licenses and may not sell, offer to sell or offer to buy any security. Our publications are not a recommendation to buy or sell a security.

Read More

Section 17(b) of the 1933 Securities and Exchange Act requires publishers who distribute information about publicly traded securities for compensation, to disclose who paid them, the amount, and the type of payment. In order to be in full compliance with the Securities Act of 1933, Section 17(b), we are disclosing that SMMG is compensated $5,000 per month by Plandai Biotechnology for content development. Neither SMMG nor anyone associated with it owns shares in PLPL.

For more information: http://www.stockmarketmediagroup.com.

Read more:
Plandai Biotechnology Expanding Footprint of Phytofare into U.S. with Continued Sales - Yahoo Finance

Popular TED Talks explore future of agricultural innovation, biotechnology – Genetic Literacy Project

The well-known TED Talks is a clearinghouse of big thinkers and big ideas, and quite a few of them have focused on agriculture and food production over the years.

Engineering Drought Resistance Jill Farrant, a Professor of molecular and cell biology at University of Cape Town, South Africa, is studying how ancient DNA can be turned on to help important food crops fight off drought. She and colleagues have been studying resurrection plants to achieve this goal. Resurrection plants are those that can undergo extreme drought without water for months or even years. Then when the next rain comes along within 12 to 48 hours the plants green up and start growing again.

Farrants How We Can Make Plants Survive Without Water TED Talk featured her research into how resurrection plants work and if those special characteristics could be transferred into other plants, especially food crops.

Robot Swarms Vijay Kumar, Dean of the University of Pennsylvanias School of Engineering and Applied Science, wowed his TED Talk audience with his presentation titled The Future of Flying Robots. His lab is developing autonomous flying robots that use onboard sensors, cameras, and laser scanners to map the environment it is in and avoid obstacles while navigating.

All agriculture-related TED Talks can be found at ted.com/topics/agriculture.

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion, and analysis. Read full, original post:TED Talks Take on Agriculture Innovation

For more background on the Genetic Literacy Project, read GLP on Wikipedia

Read the rest here:
Popular TED Talks explore future of agricultural innovation, biotechnology - Genetic Literacy Project

Don't Worry If You're a Worrier It Could Be Good for You – Live Science

Although worrying does not feel good, it may have surprising benefits, when done in just the right amount, two psychology researchers argue in a new editorial.

For example, worrying may motivate people to engage in behaviors that are potentially beneficial to their health, the researchers said. People who are worried may slather on sunscreen to help prevent skin cancer, and women may get regular mammograms to screen for breast cancer, the researchers said.

"Despite its negative reputation, not all worry is destructive or even futile," lead author Kate Sweeny, a psychology professor at the University of California, Riverside, said in a statement.

However, the relationship between worry and behaviors that are potentially beneficial to people's health is complex and seems to depend on how much a person worries, the authors noted. [9 DIY Ways to Improve Your Mental Health]

Previous research has shown that "women who reported moderate amounts of worry, compared to women reporting relatively low or high levels of worry, are more likely to get screened for cancer," Sweeny said. "It seems that both too much and too little worry can interfere with motivation, but the right amount of worry can motivate without paralyzing."

In the editorial, the authors looked at research that had examined both the downsides and upsides of worry. For example, studies have linked excessive worrying with such downsides as anxiety, fatigue, trouble concentrating and sleep problems, the researchers wrote in the editorial, published April 18 in the journal Social and Personality Psychology Compass.

However, other research has shown that worrying can also have positive effects on behavior, the researchers said. Worrying may not only motivate people to take action, as in using sunscreen, but also may allow people to better prepare themselves for negative experiences in their lives, and develop a greater appreciation for positive experiences in their lives.

For example, if a person is worrying and bracing for the worst in a certain situation, and then if that person receives the bad news they have been bracing for, the person's disappointment will be mitigated by their worrying. However, if that same person receives good news instead of the bad news they were expecting, then the person may experience more excitement than if he or she had not been worried in the first place, the researchers said. [5 Wacky Ways to Quantify Happiness]

The new paper "flies in the face of what a lot of people may assume when it comes to worry," said Simon Rego, an associate professor of clinical psychiatry and behavioral sciences at Albert Einstein College of Medicine in New York. However, the idea that worry may have an upside is definitely valid, said Rego, who was not involved in writing the editorial.

Moreover, there are other psychological states, and emotions, that may feel unpleasant to the person who is experiencing them, but that can nonetheless be useful to this person. For example, experiencing justifiable anger may motivate people to "defend themselves or correct a sense of injustice," Rego told Live Science. If a person sees someone else key-scratching his or her car, then experiencing anger would motivate the car owner to do something to rectify the injustice that is happening, he said.

Originally published on Live Science.

Read more from the original source:
Don't Worry If You're a Worrier It Could Be Good for You - Live Science

The behavioral science behind why people don't return their shopping carts – Fast Company

In its earnings statement today, Tesla announced revenues of $2.7 billion for the quarter, above the estimated $2.6 billion. Losses came in at $1.33 per share, much greater than the anticipated 81 cents per share. In after-hours trading, TSLA shares spiked up a percent before trending downward. In its shareholder letter the company revealed a few key items:

Vehicle production is up 64% year-over-year and deliveries were a record25,051 for the quarter

The company is planning to manufacture 5,000 Model 3s per week later this year. Sometime next year,Tesla wants to boost that number to 10,000 vehicles per week (this is something of an explanation for how it plans to ramp up production to meet its goal of 500,000 cars in 2018)

Expect 100 more retail, delivery, and service locations to come this year globally

25,000 new charging stations are coming in 2017

This quarter Tesla brought its computer vision and self-driving tech stack entirely in-house to build the technology more rapidly

Good news for solar: Roughly a third of new residential deployments were to purchasing customers rather than leasing ones

In its forward-looking guidance Tesla says that by July capital expenditures will spill over $2 billion with more investment coming later in the year.

[Photo: courtesy of Tesla] RR

More:
The behavioral science behind why people don't return their shopping carts - Fast Company

CURE Pharmaceutical Adds Industry Veteran Anti-Aging Specialist and Medicinal Cannabis Supporter Alan Einstein to … – EconoTimes

CURE Pharmaceutical Adds Industry Veteran, Anti-Aging Specialist and Medicinal Cannabis Supporter, Alan Einstein, to Its Board of Directors

OXNARD, Calif., May 03, 2017 -- CURE Pharmaceutical (OTCQB:CURR), (CURE), a leading disruptive drug delivery technology company researching cannabinoid molecules for various healthcare applications, today announces the appointment of Dr. Alan E. Einstein to its board of directors.

Dr. Alan Einstein, grandson to famed physicist Albert Einstein, has been practicing medicine since 1996. Currently working at EMC2Care in Alpharetta, Ga., he is considered a thought leader in metabolic syndrome and its role in weight gain and overall health and longevity. He has also conducted extensive research utilizing umbilical cord blood stem cells, with an interest in Parkinsons disease and assisted Senator David Shafer in writing and passing Georgias only Cord Blood stem cell bill. Furthermore, in July 2006, Dr. Einstein was appointed to the, Commission for Newborn Umbilical Cord Blood Research and Medical Treatment by Georgia Governor Sonny Perdue.

We here at CURE Pharmaceutical are always looking for innovators to be a part of our board of directors, to help us understand the needs in specific treatment areas, said Rob Davidson, CEO of CURE Pharmaceutical. Dr. Einsteins addition to our board allows for increased depth in our medical expertise as we continue to work to expand our technical capabilities across all these specific areas. We look forward to utilizing his specific knowledge and experience as we continue to rapidly grow.

Along with his work and knowledge in the areas of anti-aging and anti-inflammatory medicine, Dr. Einstein is a firm believer in the study of cannabis and cannabinoids for medicinal benefits. CURE is taking a leadership role in optimizing plant based cannabinoids with a strategy to bring new cannabinoid molecules to the market through the FDA regulatory approval process while utilizing the companys proprietary delivery technologies.

I am looking forward to being a part of CURE Pharmaceuticals board of directors. Their drug delivery technologies are innovative technologies that I believe will benefit a growing number of people who require alternate ways to take medications, instead of the standard pill, Dr. Einstein said. Additionally, I am excited to see the upcoming research and partnerships that the company is planning in the medicinal cannabinoid area, as this is a growing market area that needs more research to help prove the benefits of these molecules.

Dr. Einstein earned a bachelors of science degree in Physical Chemistry from The University of Florida. Subsequently, he earned his medical degree from The College of Osteopathic Medicine and Surgery in Des Moines, Iowa. Dr. Einstein then went on to complete his Internship and Residency training at The Johns Hopkins University School of Medicine/Sinai Hospital program in Internal Medicine, in Baltimore, MD.

About CURE Pharmaceutical Cure Pharmaceutical is a fully integrated specialty pharmaceutical/bioscience company with disruptive proprietary drug delivery technologies for a broad range of molecules serving the pharmaceutical, biotech, veterinarian, medical foods markets, cannabinoid molecules and new chemical entities (NCEs). Cure has an industry leading full service cGMP manufacturing facility and is a preeminent developer and manufacturer of a patented and proprietary delivery system (CureFilm), the most advanced oral thin film on the market today. Cure has developed an array of products in cutting-edge delivery platforms. Cure is well positioned in thepharmaceutical cannabis sector and is developing a global footprint with partners in the U.S., Canada, Israel and Germany, among other markets. The Companys mission is to create solutions to improve the overall quality of life and deliver proven drugs in a fast and efficient manner.

For more information about CURE Pharmaceutical, please visit its website at http://www.curepharmaceutical.com.

Forward-looking statements This press release contains forward-looking statements, which are subject to risks and uncertainties. All statements, other than statements of fact, including those statements with respect to the Company's business development, are forward-looking statements.Forward-looking statements speak only as of the date made and are not guarantees of future performance. We undertake no obligation to publicly update or revise any forward-looking statements.

Human Life Could Be Extended Indefinitely, Study Suggests

Goosebumps, tears and tenderness: what it means to be moved

Are over-the-counter painkillers a waste of money?

Does an anomaly in the Earth's magnetic field portend a coming pole reversal?

Immunotherapy: Training the body to fight cancer

Do vegetarians live longer? Probably, but not because they're vegetarian

Could a contraceptive app be as good as the pill?

Some scientific explanations for alien abduction that aren't so out of this world

Society actually does want policies that benefit future generations

Six cosmic catastrophes that could wipe out life on Earth

Big Pharma Starts Using Cannabis For Making Drugs In Earnest

Do you need to worry if your baby has a flat head?

More:
CURE Pharmaceutical Adds Industry Veteran Anti-Aging Specialist and Medicinal Cannabis Supporter Alan Einstein to ... - EconoTimes

Will Pro Sports Teams Ever Figure Out How to Quantify How Well Teammates Get Along? – Slate Magazine

David Ross, right, congratulates Jon Lester for pitching a complete game for the win against the Los Angeles Dodgers on June 1 in Chicago.

Jon Durr/Getty Images

What makes a group of athletes greater than the sum of its parts? Is it the knowing glance that New England Patriots quarterback Tom Brady exchanges with Rob Gronkowski when he looks down the line of scrimmage? Is it the fire that the Chicago Cubs Jon Lester mustered after his personal catcher David Ross trotted out to the mound to dispense some wisdom in a tense sixth inning?

Team chemistry is the most elusive factor in sportsthe holy grail of performance analytics, according to Harvard Business Review. Its only logical that certain teams get along better than others, but how important are these relationships, and can teams optimize them?

The fact that the sports worlds intangibles seem, by definition, immeasurable make them an irresistible challenge for researchers whove figured out how to quantify so much of what happens on the field of play. Neuroscientists have claimed to measure chemistry through the synchronized heartbeats of teammates. Other researchers have examined the correlation of high fives and wins.

The rewards for solving the chemistry riddle are high, in part because maximizing chemistry would come at almost zero cost. If a team could determine that a player would contribute more of a winning attitude than another guy with a similar statistical output, theyd get that chemistry boost for freeat least until other teams figured out how to quantify that extra boon to team spirit.

Professional sports franchises are still a long way away from figuring out how to maximize their players ability to work together. Sam Miller, who wrote a feature on team chemistry for ESPN the Magazine in 2013, told me that its not like you have 25 guys, therefore you have 25 relationships. You have 25 guys, therefore you have probably billions of relationships. And Russell Carleton, who has written about the quantification of chemistry for Baseball Prospectus, says major-league clubs havent yet come close to understanding a baseball team as its own little culture. The economics of baseball ensure that in-house analytics gurus focus more on a players hard statistics than something as squirrelly as clubhouse presence. At least for now, every team would be advised to build its roster based on wins above replacement rather than, say, the alleged 10 wins worth of value that pitcher Brandon McCarthy claimed his teammate Brandon Inge contributed off the field.

In reality, were not even particularly close to developing a consensus understanding of what the term chemistry means. Analysts and academics have mountains of player performance data, but these on-field metrics can only carry their research so far. Baseball players spend more time in the relative privacy of locker rooms, dugouts, bullpens, airplanes, and hotel rooms than they do on the field. The limited access researchers have to these spaces means theyre lacking a vital source of quantifiable data. With limited inputs to calculate chemistry, statisticians have to get creative to find something measureable. But what they end up measuring might not actually be chemistry.

Take the work of Katerina Bezrukova, a professor at the University at Buffalo School of Management who has worked with Major League Baseball and the National Basketball Association to shed light on chemistrys role in team performance.* Her research focuses on the demographic fault lines in sports, intrateam divisions that develop from differences in teammates racial, ethnic, and economic backgrounds. She claims that teams must strike an optimal balance between diversity and homogeneity and that teams that fall too far on either side of the golden mean win fewer games. In an MLB season, she finds, chemistry is worth about three wins.

Although demographic factors may have some say in how a team gets along, Bezrukovas research pays little mind to players individual personalities. Thats a far more difficult element to harness, but without it you end up with a circuitous definition of chemistry. Bezrukova has found something to measure. Its just unclear what that something is.

A paper presented at this years MIT Sloan Sports Analytics Conference leans on a similar crutch. In Search of David Ross, named for the backup catcher and spiritual leader of the 2016 World Series champion Cubs, takes a stab at quantifying the indirect impact that an individual player can have on team wins through making their teammates better. The authors do some messy math to get there, employing a regression model on FanGraphs wins above replacement statistic. There is on average a 20 percent variance, they report, between a teams actual win total and the cumulative WAR of all the players on that team. They attribute half of that 20 percent gap to what they call chemistry.

If we wanted to measure chemistry for real, pro baseball would need to function as a laboratory first and a competitive arena second.

There are plenty of problems with this approach. Carleton and Miller both say such a model, which points to a negative space in the calculation of team performance and works backward to fill it in, risks sweeping a lot of unrelated stuff into the chemistry bucket. Miller points out that analysts have traditionally attributed discrepancies between team wins and cumulative WAR to a teams relative clutchnessthat is, random (well, probably random) fluctuations in how similarly skilled players perform in crucial moments throughout the season. Carleton says his concern is that the paper bundles on-field interaction effects into chemistry. His example: If shortstop A plays for a team whose pitching staff produces a lot of ground balls, he may have an inflated WAR compared with shortstop B, whose pitching staff generates a lot of fly balls. Shortstop B produces less value for his team because hes spending a lot of time twiddling his thumbs, but that doesnt necessarily mean he has bad relationships with his teammates or even that he is worse at baseball.

When I brought this up with the authors of the David Ross paper, they said their methods accommodate exactly this sort of scenario. That shortstop who is fielding a lot of infield ground balls? They argue he has good chemistry with his pitchers.

The issue here, then, isnt that the authors are bad at math. Its that their version of chemistryessentially, anything that makes teams better than the players individual characteristics might suggestis not what most of us would call chemistry.

The authors of the papera pair of economists at the Chicago Federal Reserve and a professor at the Indiana University Kelley School of Businessfound a creative workaround given their lack of access to baseball clubhouses, using publicly available player performance data to take aim at an abstract target. If we wanted to measure chemistry for real, pro baseball would need to function as a laboratory first and a competitive arena second. In this fantasyland, statisticians would have unrestricted access to clubhouse social scenes. They could track what players talked about behind closed doors and how long those conversations lasted. They could also randomize trades, testing out different players in different circumstances. Carleton argues that measuring chemistry wouldnt even be that hard in a world like this one. But sadly for researchers (and happily for players), that level of omniscience and omnipotence isnt in the offing, at least in this century.

In the present day, MLB teams use personality exams that that have little more validity than a Myers-Briggs test. But more advanced analytics may find their way into front offices soon. Bezrukova has presented her research to general managers, and Carleton also confirmed to me that in-house analysts from various teams are working on measuring chemistry. But even small breakthroughs will be hard to come by when no one knows what to look for. Until we reach a consensus view of
what chemistry means, well all just be guessing whether David Ross paternal drawl instilled just a touch more confidence in Jon Lester, and how much it matters if it did.

Correction, May 2, 2017: This piece originally misstated that Katerina Bezrukova is a psychology professor at the University of Buffalo. She is a professorat the University at Buffalo School of Management. (Return.)

See more here:
Will Pro Sports Teams Ever Figure Out How to Quantify How Well Teammates Get Along? - Slate Magazine

Commentary: Better living through chemistry – Jacksonville Journal Courier

On Earth Day, April 22, a hundred thousand people marched all across the world for science. Tens of thousands demonstrated in Los Angeles and London, while 200 people marched 200 miles north of the Arctic circle in Norway. In 600 cities on every continent, citizens and scientists carried signs like Fund science, not walls and Science trumps alternative facts. In Washington, D.C., the biggest crowd protested Donald Trumps proposed budget cuts to scientific research in public health and climate.

Trump is carrying out normal Republican politics. None of the many Republican candidates for president in 2016 thought evolution should be taught in public schools. A majority of Republican voters believe in creationism.

The issue of climate change shows the influence of political ideology on attitudes toward science. A Pew poll found that only 15 percent of conservative Republicans believe the earth is warming mostly due to human activity, 34 percent of moderate Republicans, 63 percent of moderate Democrats and 79 percent of liberal Democrats. A majority of conservative Republicans believes that climate scientists are influenced by a desire to advance their careers and political ideology, not by scientific evidence or public interest.

To put it simply, conservatives dont believe in science or scientists.

Heres how science denial works in real life. Lots of private websites offer their version of science, paid for by private money that they dont disclose, using clever tactics to pretend to search for truth. An example is the Heartland Institute, which has been denying the existence of warming for decades.

On the other side is Understanding Science, a public project of the University of California at Berkeley, funded by the federal National Science Foundation. This step-by-easy-step primer offers a balanced and authentic understanding of how science really works. But those who automatically accuse both government and the nations best universities of politicized scientific fraud would dismiss this site as propaganda. So they wont learn from it how our scientific community does a far better job of policing high standards for honesty and frankness than either politicians or corporations.

And they wont think about who pays for science: Most scientific research is funded by government grants (e.g., from the National Science Foundation, the National Institutes of Health, etc.), companies doing research and development, and non-profit foundations.

Public and private sources have different priorities for funding scientific research. My nephew works on the development of a drug to stop Alzheimers for a biotechnology company formed by scientists and venture capitalists. Their research is motivated both to find better medicines for our collective health and to make money. As I approach 70, the prospect of preventing brain degeneration before it hits me is exciting. Their profit might extend my useful life.

Some privately funded scientific research is not in the public interest at all, such as the tobacco companies effort to deny the link to cancer, funneled through sciency-sounding propaganda organizations like the Heartland Institute.

The Republicans in Congress are not waging a war on all science; they quote from Heartlands fake science. They attack government-supported science because it might lead to government spending. For example, the discovery of lead in the water in Flint, Michigan, meant that old pipes must be replaced on 17,000 homes at an estimated cost of $7,500 each, totaling $127.5 million. Government-paid scientific research documented how lead affects babies brains, supported the creation of regulations which forced industry to stop using lead, compared the levels of lead in Flints water to experimental evidence on poisoning, and thus demonstrated the need for federal intervention.

Republicans in the Senate voted overwhelmingly to deny funding to deal with Flints crisis, but that effort lost by one vote. Congress authorized $170 million for Flint.

In the words of Understanding Science, Science affects your life every day in all sorts of different ways. Good public science saves lives and serves the public interest through government spending and government regulation. But those are Republican curse words. That is the deep secret behind the anti-science policies of Republicans in Congress and the White House. If they want to shrink government, they have to slow down or even stop science. They use tactics of obfuscation and delay. House Science Committee chair Lamar Smith attacked a 2015 study showing rising global temperatures. He used his old tactics, honed over decades in Congress: he demanded thousands of emails and other documents in search of malfeasance, misspent funds or corruption. He never found any, but he slowed down science he doesnt like.

This is not in our national interest. If we dont prepare for the worlds new climate, if we dont prevent health crises through regulation of pollutants, if we dont spend now on inconvenient science, we will have to spend much more later in economic and social costs. Peter Muennig, professor of public health at Columbia University, estimates that the two fewer healthy years of the 8,000 Flint children exposed to lead might cost American society $400 million.

The astrophysicist and TV explainer of science, Neil deGrasse Tyson, said, The good thing about science is that its true, whether or not you believe it.

The bad thing about Republican science politics is that our children and grandchildren will pay the price. Without science, its just fiction.

Olga Rodriguez | AP

http://myjournalcourier.com/wp-content/uploads/2017/05/web1_AP17112820985283.jpgOlga Rodriguez | AP

Steve Hochstadt is a writer, a gardener and a retired Illinois College professor of history. His column appears Tuesdays in the Journal-Courier and is available at stevehochstadt.blogspot.com.

.

Link:
Commentary: Better living through chemistry - Jacksonville Journal Courier

Dryden middle, high schools to remain closed after chemical fire … – CNYcentral.com

DRYDEN, N.Y.

Dryden Middle and High Schools will remain closed on Wednesday after closing early Tuesday due to a small chemical fire, according to school officials.

Authorities say the fire started in a trash can in a chemistry lab on school property. No one was reportedly injured during the fire.

The fire started when a student cleaning up wiped a container with a chemical on it and tossed the paper towel in the trash. Another student then threw away a wet paper in the same trash can which caused a reaction and sparked the fire.

A teacher was able to quickly put the flames out with an extinguisher. Students and faculty were instructed to evacuate the building at the time of the fire.

School officials along with the Dryden Fire Department decided it was best to dismiss school so the incident could be fully evaluated.

The Superintendent of Dryden Central Schools said the middle and high schools will stay closed on Wednesday so crews can conduct air quality tests as precaution.

Dryden Fire Department along with Dryden Ambulance, Ithaca Fire Department, Dryden Police Department, and New York State Police all were called to the scene to investigate.

Continue reading here:
Dryden middle, high schools to remain closed after chemical fire ... - CNYcentral.com

Ex-chemistry professor to run for Congress – Chemistry World (subscription)

Former chemistry professor Phil Janowicz is running for Congress for the first time in an attempt to unseat Republican Ed Royce, who has been a Californian representative for 25 years. Janowicz says he is running for Congress to oppose Trumps agenda, noting that his opponent has voted in lockstep with the president. The congressional election takes place in November 2018.

As a chemistry teacher here at California State Fullerton, I was constantly amazed by the grit and determination of my students, Janowicz said in a speech at the university on 25 April to announce his Democratic candidacy. When I learned how many of my students were struggling to meet basic food and housing needs, I decided that I had to do more than teach chemistry.

Janowicz tells Chemistry World that he was deeply affected by the plight of his students, even beyond the issue of crippling student loan debt. He recounts how many of those he taught were afraid for their parents to attend graduation due to concerns about deportation. The students, themselves US citizens, were fearful that their parents would be put at risk by attending because they lacked proper documentation.

After beginning his teaching at California State Fullerton in 2010, Janowicz left academia shortly after securing tenure to launch an education consultancy in January 2017.

In announcing his candidacy, Janowicz said he is running for Congress to resist the Trump agenda, and criticised his opponents record of voting with Trump 96% of the time. This was an apparent reference to a figure put forward by the polling data analysis website FiveThirtyEight to reflect how often Royce voted in line with the presidents positions.

Janowicz is concerned about the lack of scientists and individuals with science, technology, engineering and mathematics backgrounds in Congress. We need to tackle the problems of today with data we need to bring scientists back into public office, he says. Janowicz points to a proposal from the Trump administration to pull the earth science division out of Nasa, and warns that this will stymie the agencys ability to gather critical data from its satellites. If they cant collect the data, we cant even report on what is going on, he says.

Nevertheless, Janowicz acknowledges that going up against a Washington DC career politician will not be easy. He has raised about $30,000 (23,000) over the past few days, and the goal is at least $200,000 by late June when the filing period ends. Meanwhile, records indicate that Royces campaign has raised over $2.8 million.

See more here:
Ex-chemistry professor to run for Congress - Chemistry World (subscription)

Puma Biotechnology (PBYI) Q1 Earnings: Stock to Disappoint? – Zacks.com

Puma Biotechnology, Inc. (PBYI - Free Report) is expected to report first-quarter 2017 results later this month. The companys earnings track record is disappointing as it missed estimates in three of the trailing four quarters and met expectations in one. The company had an average negative surprise of 3.23% in the last four quarters.

Pumas shares have outperformed the Zacks classified Medical-Biomedical and Genetics industry, year to date. Shares of the company gained 27.2% so far this year, while the industry recorded an increase of 5.5%.

In the last reported quarter, Puma posted a negative surprise of 0.99%. Lets see how things are shaping up for this announcement.

Factors at Play

Being a development-stage company, Puma Biotech does not have any approved product in its portfolio. Thus, investor focus should remain on updates pertaining to the development of neratinib, its lead pipeline candidate.

The candidate is currently under review in both the U.S. and the EU for the extended adjuvant treatment of HER2-positive early-stage breast cancer in patients who have previously been treated with Herceptin-based adjuvant therapy.

Moreover, several phase II combination studies on neratinib for the treatment of breast cancer are currently underway.

In Apr 2017, Puma presented encouraging additional data from breast cancer studies at the San American Association for Cancer Research Annual (AACR) on neratinib. These include interim data from a phase II study in patients with HER2-positive early stage breast cancer who had completed trastuzumab-based adjuvant therapy; interim phase I/II data from the NSABP FB-10 trial of neratinib plus Kadcyla (T-DM1) in HER2-positive MBC; and phase II data from SUMMIT study in HER2-negative breast cancer patients with HER2 mutations.

Puma anticipates more data updates in the second quarter. These include additional data from the phase III study on neratinib in third-line HER2-positive metastatic breast cancer patients and data from a phase II study on neratinib in HER2-positive metastatic breast cancer patients with brain metastases.

Earnings Whispers

Our proven model does not conclusively show that Puma Biotech is likely to beat estimates this quarter. That is because a stock needs to have both a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) for this to happen. That is not the case here as you will see below.

Zacks ESP:TheEarnings ESP, which represents the difference between the Most Accurate Estimate and the Zacks Consensus Estimate, is pegged at 0.00%. This is because both the Most Accurate Estimate and the Zacks Consensus Estimate stand at a loss of $2.08. You can uncover the best stocks to buy or sell before theyre reported with our Earnings ESP Filter.

Zacks Rank:Puma Biotechs carries a Zacks Rank #4 (Sell). As it is that we caution against stocks with a Zacks Rank #4 or 5 (Strong Sell) going into the earnings announcement, especially when the company is seeing negative estimate revisions.

Other Stocks That Warrant a Look

Here are some health care stocks that you may want to consider as our model shows that these have the right combination of elements to post an earnings beat this quarter.

Conatus Pharmaceuticals Inc. (CNAT - Free Report) is scheduled to release results on May 4. The company has an Earnings ESP of +57.14% and a Zacks Rank #3. You can seethe complete list of todays Zacks #1 Rank stocks here.

ImmunoGen, Inc. (IMGN - Free Report) is scheduled to release results on May 5. The company has an Earnings ESP of +8.33% and a Zacks Rank #3.

FIBROGEN INC (FGEN - Free Report) is scheduled to release results on May 8. The company has an Earnings ESP of +23.81% and a Zacks Rank #3.

Will You Make a Fortune on the Shift to Electric Cars?

Here's another stock idea to consider. Much like petroleum 150 years ago, lithium power may soon shake the world, creating millionaires and reshaping geo-politics. Soon electric vehicles (EVs) may be cheaper than gas guzzlers. Some are already reaching 265 miles on a single charge.

With battery prices plummeting and charging stations set to multiply, one company stands out as the #1 stock to buy according to Zacks research.

It's not the one you think.

See This Ticker Free >>

See the original post:
Puma Biotechnology (PBYI) Q1 Earnings: Stock to Disappoint? - Zacks.com

Around the Pier: The Bioengineering Behind the Beauty – Scripps Oceanography News

Marine phytoplankton are famously photogenic.

Take, for instance, diatoms. They are among the most common type of phytoplankton and are especially breathtaking: their cell walls are made of silica, a glass-like compound, and take a variety of forms including discs, tubes, and star-like structures.

Scientists have long sought to understand the factors that contribute to the diversity of phytoplankton.

Presumably all these different shapes have some ecological meaning, said Andrew Barton, an assistant professor at Scripps Institution of Oceanography and the Biological Sciences Division at the University of California San Diego. Some shapes might be hard to eat, or maybe are advantageous for acquiring scarce resources.

Barton has just received the Simons Foundation Early Career Investigation in Marine Microbial Ecology and Evolution Award, which will support an interdisciplinary research project to attempt to answer this question.

The project will use a combination of underwater microscope data from the Scripps Pier Plankton Camera operated by the Jaffe Laboratory for Underwater Imaging, environmental data from the Southern California Coastal Ocean Observing System (SCCOOS), and numerical models that simulate plankton communities to understand the ecological reasons for the poorly understood diversity in phytoplankton shapes and sizes.

The Scripps Plankton Camera is an underwater microscope deployed at the Scripps Pier that uses real-time image processing and object detection to monitor plankton species and abundance. Barton and his team will combine data collected by the microscope and the SCCOOS environmental data to look for correlations between environmental conditions and abundance of different kinds of plankton over time. The information they gather will help researchers understand the local environment better. Barton and his team will also create numerical models to extrapolate the trends they see to the rest of the ocean.

We can take what we learn from the data at Scripps Pier and try to extrapolate that to a larger-scale perspective, Barton said. For example, where in the global ocean is it advantageous to be a spherical cell? Where it is advantageous to form large colonies of cells? We can try to make some estimates of how cell and colony morphology vary across the planet.

The outcomes of the project could also help answer oceanographic questions beyond phytoplankton ecology. Phytoplankton are an important part of the carbon cycle and their contributions to carbon dioxide uptake from the atmosphere and oxygen creation is a significant factor in most oceanographic and climate models.

Most models and theories about how phytoplankton do what they do are predicated on them being spheres, which is obviously untrue, Barton said.

The size and shape of organisms in the ocean is important in determining where carbon and energy go in the food web, and whether the carbon absorbed will be exported from the ocean's surface to the deep sea or sediments. Providing updated information on phytoplankton morphology and how it varies throughout the worlds oceans could improve sciences understanding of the carbon cycle.

For example, if you have a really dense large cell like a diatom, it will sink from the ocean's surface, resulting in a loss of organic matter, Barton said, whereas if you have a small cell, it may just stay near the surface and be recycled locally.

The interdisciplinary research will involve Jules Jaffe, a research oceanographer in the Marine Physical Laboratory at Scripps, Paul Roberts, an engineer in Jaffes lab, and Peter Franks, a professor of biological oceanography who will help the team estimate water column turbulence and understand how turbulence in the ocean shapes cell and colony morphology.

I'm really grateful for the Simons Foundation support and happy that we now have the team and the tools to do some compelling and important science, Barton said.

And as Barton is a relatively new faculty member, this big project will be an excellent opportunity for him to collaborate with other researchers at Scripps.

This is kind of a kick-off in terms of collaborating with a Scripps team and using data collected here at the institution, he said. Im very excited.

Mallory Pickett

The rest is here:
Around the Pier: The Bioengineering Behind the Beauty - Scripps Oceanography News

Clemson’s 15 patents in 2016 span bioengineering, advanced materials – Clemson Newsstand

CLEMSON, South Carolina Rapid diagnostic tests for point-of-care diagnostics, diabetic-resistant coatings, HIV inhibitors and an impact-resistant, corrosion-prohibiting coating were among the 15 innovations for which Clemson University researchers received patents in 2016.

Tanju Karanfil, vice president for research at Clemson University, says the patent awards are one example of the impact Clemson makes on the region. Image Credit: Craig Mahaffey / Clemson University

The Clemson University Research Foundation(CURF) facilitates and manages technology transfer for Clemson faculty. Collaboration between researchers and CURF has produced more than 150 patents that are nowavailable to the private sector for licensing.

The patent recipients received special recognition recently at an annual award event sponsored by theClemson Inventors Club, a select group of faculty chosen for their high level of research activity, which often produces inventions.

Invention and innovation in research are just a few ways Clemson impacts the world, said Tanju Karanfil, vice president for research at Clemson. Congratulations to all the inventors for their hard work and dedication to academic research.

Bob Quinn, executive director of theSouth Carolina Research Authority (SCRA) outlined the new vision for the organization.

The patent awards are a great representation of the innovation happening at Clemson, Quinn said. We were honored to be able to share how SCRA works with innovators to commercialize their technologies.

Our annual patent awards recognize the quality of the research being done at Clemson, said Casey Porto, executive director of the foundation. Its a privilege to honor these researchers and celebrate their contributions to innovation that starts at Clemson and moves into the marketplace.

For a complete list of 2016 Clemson patents and recipients,click here.

For a complete list of all patents awarded to Clemson faculty, click here.

END

Read this article:
Clemson's 15 patents in 2016 span bioengineering, advanced materials - Clemson Newsstand